MST1/2 in PDGFR-α+ cells negatively regulates TGF-β-induced myofibroblasts accumulation in renal fibrosis by Yina An (11511342)

Sholl analysis of intersections, branching points, tips, and dendritic lengths made by white and gray matter astrocytes in SIB and control animals. by Kim M. Lee (437943)

Recent trends in white shark relative abundance. by Tobey H. Curtis (576240)

“…<p>Estimates of relative change in abundance (filled circles) with 95% credible intervals (dashed lines) for any reference year between 1990 and 2008 assuming no change in observation effort (black plot), a 25% and 50% increase in observation effort (green and red plots, respectively), and a 25% and 50% decrease in observation effort (blue and purple plots, respectively) for the original sightings time series from 1990 to 2009 (a) and the time series with sightings that occurred near Monomoy Island during that time frame removed (b).…”

Evolution of the short-term TEER in Calu-3 cell monolayers during the monolayer maturation. by Aizat Turdalieva (2512252)

Animals fed heat-killed HT115 have an impaired phenotype after anoxia treatment. by Bobby L. LaRue (231047)

“…<p>N2 adult hermaphrodites were fed either the OP50 or HT115 <i>E. coli</i> strain, raised at 25°C, transferred to heat-killed OP50 or HT115 and exposed to either three days (A) or four days of anoxia (B). …”

<i>Concatenated</i> ML tree. by Jana Kvičerová (430538)

Median phyla frequencies under conditions of LSG and HSG. by J. Max Goodson (469397)

Fibrotic changes in the murine lungs and livers of the DMSO, valsartan, and PD123319 groups. by Saori Yaguchi (418831)

“…E: The fibrosis was thinnest in the valsartan group (p<0.01). Magnification, A: X200. Scale bar, A: 50 µm. The results represent the mean ± SD. …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast... by Miguel J. Gil-Gil (3074085)

“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”

Supplementary Material for: Online Tool (Brain Assessment) for the Detection of Cognitive Function Changes during Aging by Satoh M. (7427648)

“…We standardized the raw scores (cognitive scores, CSs) using mean and standard deviation, which were 50 and 10, respectively. …”

Evaluation of HH target gene mRNA and protein expression following vismodegib treatment of canine OSA cell lines. by Vincent E. Baldanza (8781671)

“…<p>(A) The cell lines demonstrated variable decreases in some target genes at the transcript level with treatment at the determined IC₅₀ value when compared to vehicle control (DMSO) treatment. …”